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Abstract. Methanol extract of the roots of Scutellaria baicalensis effectively inhibited the 
bacterial growth of human pathogenic bacteria Staphylococcus aureus ATCC 6538, Bacillus 
cereus ATCC 21768 and Bacillus subtilis ATCC 6633 at MICs of 2,000 µg/mL. Hexane, ethyl 
acetate and aqueous residues were prepared by successively partitioning the methanol extract 
with hexane and ethyl acetate. Among them, only ethyl acetate layer showed antibiotic effect; 
whereas hexane and aqueous layers were inactive against tested bacteria. The ethyl acetate 
residue was fractionated by silica gel column chromatography to afford three flavonoids and an 
oligosaccharide. Their chemical structures were elucidated as wogonin (SB1), baicalein (SB4), 
baicalin (SB5) and tetrasaccharide (SB10) on the basis of the analysis of NMR and MS 
spectroscopic data. The isolates were evaluated for in vitro inhibitory effect against human 
pathogenic bacteria using micro dilution bioassay method. Baicalein (SB4) showed a broad-
spectrum inhibition against various human pathogenic bacteria. In particular, it was found to 
potently inhibit S. aureus ATCC 6538 and B. cereus ATCC 21768 with MICs of 9.5 and 38 
µg/mL, respectively. The study results demonstrated antibiotic effect of the extracts from the 
roots of S. baicalensis and characterization of compounds isolated from the plant materials. 
Keywords: activity, flavonoid, isolation, Scutellaria baicalensis. 
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1. INTRODUCTION 
The genus Scutellaria consists of over 350 species worldwide and has been used by many 
cultures to treat a variety of medical conditions, including anxiety, nervous disorders, liver 
disease and cancers [1]. S. baicalensis is widely grown in Vietnam where root decoction has 
traditionally been used in medicine as a cancer treatment, remedy for inflammation and 
atherosclerosis [1, 2]. The flavonoids such as baicalein, wogonin, and baicalin are the major 
compounds in S. baicalensis. In recent years, the flavonoids isolated from the roots of S. 
baicalensis have demonstrated therapeutic potential for anti-inflammatory, anti-HIV, anti-human 
herpes virus type 6 (HHV-6), antioxidant, neuroprotective and anti-cancer properties [3]. The 
antibiotic activity of the roots of S. baicalensis and its constitutents are also considered because 
this plant has a wide range of uses in traditional medicine. The aim of this study, therefore, is to 
isolate and identify metabolites from the roots of S. baicalensis and to test for their antimicrobial 
activity against the growth of human pathogenic bacteria. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and culture conditions 
The extracts and the isolated compounds were tested for their antibacterial activity against 
Gram-positive bacteria such as Bacillus cereus ATCC 21768, Bacillus subtilis ATCC 6633, and 
Staphylococcus aureus ATCC 6538 which were obtained from the ATTC (Manassas, VA, USA) 
and Gram-negative bacteria such as Escherichia coli (American Type Culture Collection) ATCC 
25922, Burkhoderia cepacia ATCC 25416, Enterobacter cloacae ATCC 13047 and 
Pseudomonas aeruginosa ATCC 9027. The bacterial strains were activated on nutrient agar 
(NA), then, transferred in nutrient broth (NB) at 37 °C for 24 h. The bacterial suspensions were 
diluted with sterile saline to get a turbidity equivalent to that of the 0.5 McFarland standard.  
2.2. Plant materials 
Scutellaria baicalensis Georgi was purchased in Ninh Hiep folk medicine market in August 
2016 and identified by Mr. Nghiem Duc Trong from the Department of Botany, Hanoi 
University of Pharmacy. Materials were crushed to powdery sizes of from 0.1 to 3 mm. The root 
powder (moisture content 7-10 %) was kept in dry environment at R&D Center of Bioactive 
Compounds, Vietnam Institute of Industrial Chemistry prior to extraction experiments.  
2.3. Isolation of constituents from Scutellaria baicalensis 
The roots of S. baicalensis (2 kg) were crushed and extracted three times with methanol at 
65
o
C for 8 h and then filtrated and evaporated under reduced pressure to yield 390 g crude 
methanol extract. Then, the crude methanol extract was dissolved with 1.5 L of distilled water 
and partitioned with hexane and ethyl acetate (1.5 L; 3 times for each), consecutively. Each 
organic layer was evaporated under reduced pressure to yield hexane soluble residue (41.5 g) 
and ethyl acetate soluble residue (237.6 g). 
The hexane and ethyl acetate residue were tested by thin layer chromatography; the 
presence of flavonoids and oligosaccharides was observed in the ethyl acetate residue. The ethyl 
acetate residue (20 g) was subjected to column chromatography on silica gel (400 g silica gel 
60Å (40–63 μm), 4.5 × 70 cm) which was eluted with the gradient solvent system of 
 
 
Constitutents and inhibitory effect on human pathogenic bacteria…. 
9 
hexane/ethyl acetate (10:0; 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9, 0:10, v/v) and finally washed 
out with the mixture of ethyl acetate and methanol in the ratio of 8:2 (v/v). In the results 7 
fractions F1-F7 were yielded. Fraction 2 was fractionated on a Sephadex LH-20 column (3 g, 2.0 
× 70 cm) eluted with methanol and the selected fractions were crystallized with hexane to give 
crystals of SB1 (842.7 mg). Fraction 4 (2.986 g) was applied on a silica gel column (60 g silica 
gel 60 Å (40–63 μm), 3.0 × 40 cm), eluted with hexane/ethyl acetate (7:3; 6:4, 5:5, v/v, 240 mL 
each and fraction volume of 50 mL) to yield two pure compounds SB4 (46.7 mg) and SB5 (387 
mg). Fraction 6 (3 g) was dissolved with 150 mL of methanol and mixed with 4.5 g of silica gel 
60 Å (40–63 μm). Then, the mixture was fractionated by a silica gel column chromatography (90 
g silica gel 60Å (40–63 μm), 3.4 × 50 cm), eluted with a gradient system of ethyl 
acetate/methanol (8:2, 75:25, 7:3, 65:35, 6:4, 55:45, 5:5, 45:55, 4:6, 45:65, v:v) and then washed 
out with methanol:water in the ratio of 40:1 (v/v) to produce four fractions, F61 to F64. Fraction 
F61 was separated on a Sephadex LH-20 column (2 g, 2.0 × 50 cm) eluted with methanol to 
yield SB10 (468 mg). 
2.4. Structural characterization of the isolated compounds 
SB1: Wogonin 
ESI-MS m/z 284.07 [M+H]
+
; 
1
H-NMR ((CD3)2CO, 500 MHz): 6.328 (1H, s, H-3), 6.817 
(1H, s, H-6), 8.122 (1H, dd, J=7 Hz, J= 1.5 Hz, H-2’), 7.642 (2H, m, J= 8,5 Hz, H-3’, H-5’), 
7.646 (1H, m, H-4’), 8.122 (1H, dd, J=5Hz, J=3,5 Hz, H-6’); 13C-NMR ((CD3)2CO, 125 MHz): 
164.64 (C-2), 106.25 (C-3), 183.45 (C-4), 150.93 (C-5), 158.46 (C-8), 158.03 (C-7), 99.99 (C-
6), 130.26 (C-9), 105.62 (C-10), 132.50 (C-1’), 127.80 (C-2’, C-6’), 128.93 (C-3’, C-5’), 132.96 
(C-4’).  
SB4: Baicalein 
ESI-MS m/z 293.2 [M+Na]
+
, m/z 271.2 [M+H]
+
;  
1
H-NMR ((CD3)2CO, 500 MHz): 6.76 
(1H, s, H-3), 12.76 (1H, s, 5-OH), 6.68 (1H, s, H-8), 8.07 (2H, dd, J= 1Hz, J= 7.5 Hz, H-2’, H-
6’), 7.58 (2H, m, H-3’, H-5’), 7.6 (1H, m, H-4’); 13C-NMR ((CD3)2CO-d6, 125 MHz): 164.75 
(C-2), 105.86 (C-3), 183.52 (C-4), 147.87 (C-5), 153.82 (C-6), 151.70 (C-7), 94.9 (C-8), 130.09 
(C-9), 105.59 (C-10), 132.63 (C-1’), 127.31 (C-2’, C-6’), 129.89 (C-3’, C-5’), 132.69 (C-4’). 
SB5: Baicalin 
ESI-MS m/z 447,1 [M+H]
+
; 
1
H-NMR (DMSO-d6, 500 MHz): 7.06 (1H, s, H-3), 7.01 (1H, 
s, H-8), 8.07 (2H, m, H-2’, H-6’), 7.61 (2H, m, H-3’), 7.63 (1H, m, H-4’), 12.60 (1H, s, 5-OH), 
8.69 (1H, s, 6-OH); 
13
C-NMR (DMSO-d6, 125 MHz): 163.55 (C-2), 106.14 (C-3), 182.56 (C-4), 
146.78 (C-5), 130.62 (C-6), 151.28 (C-7), 93.74 (C-8), 149.21 (C-9), 104.76 (C-10), 130.85 (C-
1’), 126.39 (C-2’, C-6’),129.18 (C-3’, C-5’), 132.06 (C-4’), 99.93 (C-1’’), 72.81 (C-2’’), 75.25 
(C-3’’), 71.33 (C-4’’), 75.51 (C-5’’), 170.08 (C-6’’). 
SB10: Tetrasaccharide ( (O-α-D-glucopyranosyl-(1→2)-O-β-D-fructofuranosyl-(1→6)-O-
α-D-glucopyranosyl-(1→2)-O-β-D-fructofuranoside). 
ESI-MS m/z 689.1 [M+Na]
+
; 
1
H-NMR (CD3OD, 500 MHz): 5.156 (1H, s, H-1), 3.737 (1H, 
s, H-2), 3.799 (1H, t, H-3),  3.519 (1H, t, H-4),4.626 (1H, t, H-5), 3.628 (1H, t, H-6), 3.705 (1H, 
s, H-7), 3.985 (1H, s, H-9),3.767 (1H, s, H-10), 4.530 (1H, t, H-11), 3.417 (1H, m, H-12), 5.148 
(1H, s, H-1’), 3.726 (1H, s, H-2’), 3.777 (1H, t, H-3’), 3.501 (1H, t, H-4’), 3.598 (1H, t, H-6’), 
3.690 (1H, s, H-7’), 3.888 (1H, s, H-9’),3.761 (1H, t, H-10’), 4.514 (1H, t, H-11’), 3.410 (1H, m, 
H-12’); 13C-NMR (CD3OD, 125 MHz): 93.80 (C-1), 72.87 (C-2), 76.59 (C-3), 69.26 (C-4), 
77.88 (C-5), 62.69 (C-6), 65.76 (C-7), 99.15 (C-8),77.85 (C-9), 76.59 (C-10), 83.03 (C-11), 
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62.52 (C-12), 98.00 (C-1’), 71.53 (C-2’), 76.11 (C-3’), 71.09 (C-4’), 77.81 (C-5’), 64.45 (C-6’), 
64.97 (C-7’), 103.05 (C-8’), 77.36 (C-9’), 76.11 (C-10’), 83.03 (C-11’), 62.55 (C-12’). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The 
1
H-NMR and 
13
C-NMR spectra of baicalein (SB4). NMR spectra were recorded of an 
acetone-d6 solution of SB4 on a a Bruker AMX-500 (500 MHz). Chemical shifts are given in parts per 
million (ppm) downfield from tetramethylsilane. 
2.5. Instrumental analyses  
Nuclear magnetic resonance (NMR) data of the isolated compounds were recorded on a 
Bruker AMX-500 (500 MHz) spectrometer (Bruker Analytische Messtechnik GmbH, 
Rheinstetten, Germany) at 500 MHz for 
1
H-NMR spectra and 125 MHz for 
13
C-NMR spectra 
(Fig. 1). Tetramethylsilane (TMS) is using as an internal standard. The electrospray ionization 
mass spectra (ESI-MS) of the isolated compounds were recorded on an MSD1100 single-
quadruple mass spectrometer equipped with an electrospray ionizer (Hewlett-Packard Co., Palo 
Alto, CA, USA).  
Chemical structures of the isolates were determined by NMR data analyses and comparison 
with those of the previously reported in literature.   
2.6. In vitro antibacterial assay against human pathogenic bacteria 
All bacterial strains were grown on nutrient agar (NA) and nutrient broth (NB) at 37°C for 
24 h and then suspended in sterile saline at a density equivalent to that of the 0.5 McFarland 
standards. Bacterial suspensions with a concentration of 10
5
cfu/mL were used for in vitro 
antibacterial activity test.  
In vitro antibacterial assay was conducted in 96-well microtiter plates on the basis of a 
modification of broth micro-dilution method [4]. The tested materials were dissolved in dimethyl 
sulfoxide (DMSO) to get the stock solutions with dilution factor of 100. The working 
concentrations of the extracts and isolated compounds ranged from 9.5 to 2,000 μg/ml. DMSO 
(2 %) was used as the negative control, at which it did not affect the bacterial growth. 
Chloramphenicol (Sigma-Aldrich, USA) was used as a positive control against all the bacteria. 
The assay was repeated twice with two replicates for each sample against the individual bacterial 
species at all the test concentrations. The minimum inhibitory concentration (MIC, µg/mL) was 
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determined as the lowest concentration that completely inhibited the growth of the bacteria 
which were incubated at 37°C for 1 day and 2 days. The optical density (OD) was measured 
spectro-photometrically at 600 nm. The growth inhibition for each dilution was determined 
using the formula: 
Percent inhibition (%) = 100 × [1 – OD of treated well/ OD of negative control well], 
where OD is the optical density of each well 24h after incubation; values of OD of negative 
control well and OD of treated well were corrected with OD of its blank wells corresponding to 
each concentration. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and characterization of metabolites from the roots of S. baicalensis 
Compounds SB1, SB4 and SB5 were detected to be flavonoids which produced dark green 
color with FeCl3 and yellow color with KOH/ethanol reagents. Their 
13
C-NMR spectra data 
displayed that all of the compounds have 15 carbons in flavonoid skeleton which consists of two 
phenyl rings (A and B-rings) and heterocyclic ring (C-ring). In the A-ring of each structure, a 
carbonyl group at C-4 was presented in a range of δ 183.45-183.56 ppm; two oxygenated 
aromatic carbons at C-5 and C-7in SB1 did from δ 150.62 to 158.03 ppm. The heterocyclic ring 
revealed the presence of phenolic group in a range of δ 7.06-8.69 ppm in 1H-NMR spectra of the 
three compounds. The 
1
H-NMR spectrum of SB1 displayed a signal at δ 6.328 ppm that is 
expected for an olefinic proton and appeared as a singlet. A signal δ 6.817 ppm also appeared as 
a singlet, which is assigned as a proton at C-6 (δ 99.99 ppm) in the A-ring. Two sets of protons 
in the B-ring (H-2’, H-6’ and H-3’, H-5’) are symmetrical in each pair. Its 13C-NMR spectral 
data showed that the δ 158.46 ppm represented at C-8 position of A-ring connected to a methoxy 
group. By the 
1
H-NMR and
13
C-NMR spectra data, SB1 was determined to be wogonin by 
comparison with NMR spectral data from previously published literatures [5]. SB4 was deduced 
to be baicalein based on the analysis of 
1
H- and 
13
C-NMR spectra (Figure 1). In the structure of 
bacalein, aromatic oxygenated carbons δ 147.87 (C-5), 153.82 (C-6) and 151.70 (C-7) in A-ring 
are connected to hydroxyl groups may be corresponding in antibacterial activity (Figure 2) [6].  
Structure of compound SB5 is the similar to that of compound SB1. The 
13
C-NMR 
spectrum of SB5 showed 19 signals arising from one flavone skeleton including 15 carbons (C-2 
to C-10 and C-1’ to C-6’). 1H-NMR and 13C-NMR spectra of SB5 revealed a hexanoic pattern 
having an acid group (δ 71.33, 72.81, 75.25, 75.51, 99.93, 170.08 ppm), whose chemical shift 
values were in good agreement with those of β-D-glucuronic acid. Based on symmetry 
considerations, two carbon atoms of the B-ring were chemically equivalent; hence, only 13 
signals from the 15 carbons were observed. Instead of a hexose, a hexanoic acid was present: the 
strongly deshielded resonance from the carbon atom at δ 170.08 ppm is the result of an acid 
functional group. The NMR data obtained for compound SB5 are consistent with that of baicalin 
[7]. 
Compound SB10 was obtained as white colorless crystals. The 
13
C-NMR and JMOD 
spectra showed twenty-four carbons in the range from δ 62.55 to 103.05 ppm, which is 
characteristic of a tetrasaccharide corresponding to the carbons bonded with oxygen at position 
of those in glucose and fructose. Its 
1
H-NMR spectrum showed anomeric proton signals and 
symmetry in pairs. Two signals at δ 5.156 (1H, s, H-1) and 5.148 (1H, s, H-1’) were determined 
to be two protons anomeric in two glucose moieties. Two signals of anomeric carbons at 93.80 
and 98.00 ppm together with two quaternary oxygenate carbons at δ 99.15 and 103.05 suggested 
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that this compound comprised two glucose molecules and two fructose molecules. Compared 
with the previously reported data in the literature, compound SB10 was identified as O-α-D-
glucopyranosyl-(1→2)-O-β-D-fructofuranosyl-(1→6)-O-α-D-glucopyranosyl-(1→2)-O-β-D-
fructofuranoside (Figure 3), an analog of sucrosyl-(1→2)- β- isomaltulose [8].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Chemical structure of compounds isolated from the roots of S. baicalensis. 
3.2. Antibacterial activity of layers and isolated compounds from the roots of S. baicalensis 
In the study, the methanol extract and the two compounds as SB1 and SB4 were selected 
for testing against seven human pathogenic bacteria. MICs values (μg/mL) at 1 day and 2 days 
after incubation were detected by visualizing with naked eye and listed in Table 1. SB1 was not 
active against all bacterial strains at the range of tested concentrations. Methanol extract of S. 
baicalensis inhibited the bacterial growth of S. aureus ATCC 6538, B. cereus ATCC 21768 and 
B. subtilis ATCC 6633 with the same MICs of 2,000 µg/mL. SB4 was found to potently inhibit 
bacterial strains such as S. aureus ATCC 6538 and B. cereus ATCC 21768 with MICs of 9.5 and 
38 µg/mL, respectively.  
Table 1. MIC values of the methanol extract and isolated compounds from S. baicalensis against human 
pathogenic bacterial strains. 
Bacterial strains 
MIC (μg/mL)a 
SB1 SB4 Methanol extract Chl 
S. aureus ATCC 6538 - 9.5
b
 (19)
c
 2,000 (2,000) 40 (40) 
B. cereus ATCC 21768 - 38 (75) 2,000 (2,000) 40 (40) 
B. subtilis ATCC 21768 - 1,000 (2,000) 2,000 (2,000) 40 (40) 
B. cepacia ATCC 25416  - 1,000 (>2,000) - 20 (20) 
aMIC: minimum inhibition concentration (μg/mL) is the lowest concentration of antimicrobial agent that 
completely inhibits growth of the organism in microdilution wells as detected by the naked eye. 
b
MIC 
values at 1 day after incubation. 
c
(MIC) values at 2 days after incubation. (-) no inhibition. SB1: wogonin; 
SB4: baicalein. Chl: chloramphenicol. 
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Figure 3. Fig 3.1: Effects of baicalein (SB4) and methanol extract (ME) of Scutellaria baicalensis on the 
bacterial growth of Bacillus cereus ATCC 21768 at 1 day (1 DAT) and 2 days (2 DAT) after incubation.  
              Fig. 3.2. In vitro dose-response of baicalein for antibacterial activity against B. cereus ATCC 
21768. (A) Dose-effect and (B) Log of dose-effect curves. 
Table 2. Calculated inhibitory concentrations IC50 and IC90 of baicalein causing 50 % and 90 % inhibition 
against the bacterial growth of Bacillus cereus ATCC 21768. 
 
 
 
 
 
a
Inhibition values were calculated on the basis of Probit analysis of dose-response data expressed in 
Fig. 3.2. 
b
 95 % confidence interval. 
Besides, it significantly affected the bacterial growth of B. subtills ATCC 6633 and B. 
cepacia ATCC 25416 strains at 1,000 µg/mL. The effects of SB4 and methanol extract on the 
bacterial growth of B. cereus ATCC 21768 were further tested by broth micro-dilution method 
in 96-well places and their inhibition rates were presented in Figure 3.   
Baicalein (SB4) showed a dose-response activity against B. cereus ATCC 21768 (Figure 
3.2); it effectively inhibited the bacterial growth with low IC50 and IC90 values in a range of 25.8 
to 109.7 µg/mL (Table 2). The difference between the antibacterial efficacy of SB1 and SB4 
against B. cereus ATCC 21768 may be due to a different pattern of hydroxyl and methoxy 
groups at positions C-5, C-6, C-7 and C-8 in A-ring of each compound. Three bacterial strains E. 
coli ATCC 25922, P. aeruginosa ATCC 9027 and E. cloacae ATCC 13047 were resistant to all 
of the test materials (data not shown). 
In addition, our results of the potent antibacterial activity against B. cereus ATCC 21768, 
notably, the inhibition of baicalein against the bacterial growth of S. aureus ATCC 6538 is 
highly paid attention by natural product chemists and be evident by certain studies in synergistic 
effects of baicalein with other antibiotics such asciproﬂoxacin, oxacillin and vancomycin [10].   
4. CONCLUSIONS 
The present study exhibited that methanol extract of S. baicalensis had an inhibition for 
bacterial growth of S. aureus ATCC 6538, B. cereus ATCC 21768 and B. subtilis ATCC 6633. 
Conc. (µg/mL) 1 DAT 2 DAT 
IC50  25.8
a
 (11.0- 60.5)
b
 32.7 (5.6 - 56.8) 
IC90  78.6 (40.4-152.9) 109.7 (55.3 -164.0) 
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Its major constituents were identified as wogonin (SB1), baicalein (SB4), baicalin (SB5) and a 
tetrasaccharide (SB10). Of them, SB4 strongly inhibited bacterial strains such as S. aureus 
ATCC 6538, B. cereus ATCC 21768 and B. subtilis ATCC 6633. Our study suggested that S. 
baicalensis is a good plant resource containing potent antibacterial substances for developing 
botanical drugs to treat human bacterial pathogens.  
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